Clinical trial
Immunogenicity and Safety of Tetraxim Versus Local DTP + IPV
NCT00319852 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Immunogenicity and Safety of Tetraxim Versus Local DTP + IPV
- Lead sponsor
- Sanofi
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- April 30, 2006
- Completion date
- July 31, 2008
- Enrollment
- 442 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
diphtheria, pertussis, poliomyelitis, tetanus